AROA BIOSURGERY ORDINARY (ARX) Short Interest
AROA BIOSURGERY ORDINARY (ASX:ARX) had 0.00% of shares reported as short positions as of 26 June 2026, representing 921 shares. AROA BIOSURGERY ORDINARY operates in the Pharmaceuticals, Biotechnology & Life Sciences industry. Source: ASIC short position report (T+4 delay).
Source: official ASIC short position report, T+4 delay. Methodology · Disclaimer — not financial advice.
ARX
Aroa Biosurgery
AROA Biosurgery Limited specializes in regenerative healing products for soft-tissue repair. It emphasizes the use of extracellular matrix (ECM) biomaterials in its offerings, giving it a niche position in the medical devices market. The company aims to improve healing outcomes and reduce healthcare costs, standing out through its innovative solutions and successful commercialization strategies.